title: High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.
abstract: AIDS dementia and encephalitis are complications of AIDS occurring most frequently in patients who are immunosuppressed. The simian immunodeficiency virus (SIV) model used in this study was designed to reproducibly induce AIDS in macaques in order to examine the effects of a neurovirulent virus in this context. Pigtailed macaques (Macaca nemestrina) were coinoculated with an immunosuppressive virus (SIV/DeltaB670) and a neurovirulent molecularly cloned virus (SIV/17E-Fr), and more than 90% of the animals developed moderate to severe encephalitis within 6 months of inoculation. Viral load in plasma and cerebrospinal fluid (CSF) was examined longitudinally to onset of AIDS, and viral load was measured in brain tissue at necropsy to examine the relationship of systemic and central nervous system (CNS) viral replication to the development of encephalitis. In all animals, plasma viral load peaked at 10 to 14 days postinfection and remained high throughout infection with no correlation found between plasma viremia and SIV encephalitis. In contrast, persistent high levels of CSF viral RNA after the acute phase of infection correlated with the development of encephalitis. Although high levels of viral RNA were found in the CSF of all macaques (six of six) during the acute phase, this high level was maintained only in macaques developing SIV encephalitis (five of six). Furthermore, the level of both viral RNA and antigen in the brain correlated with the severity of the CNS lesions. The single animal in this group that did not have CNS lesions had no detectable viral RNA in any of the regions of the brain. The results substantiate the use of CSF viral load measurements in the postacute phase of SIV infection as a marker for encephalitis and CNS viral replication.
authors.affiliation: Division of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. mczink@mail.jhmi.edu
authors.forename: M C
authors.initials: MC
authors.lastname: Zink
authors.forename: K
authors.initials: K
authors.lastname: Suryanarayana
authors.forename: J L
authors.initials: JL
authors.lastname: Mankowski
authors.forename: A
authors.initials: A
authors.lastname: Shen
authors.forename: M
authors.initials: M
authors.lastname: Piatak
authors.forename: J P
authors.initials: JP
authors.lastname: Spelman
authors.forename: D L
authors.initials: DL
authors.lastname: Carter
authors.forename: R J
authors.initials: RJ
authors.lastname: Adams
authors.forename: J D
authors.initials: JD
authors.lastname: Lifson
authors.forename: J E
authors.initials: JE
authors.lastname: Clements
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D001921:Brain / Q000473:pathology / Q000821:virology*; D018792:Encephalitis, Viral / Q000097:blood / Q000134:cerebrospinal fluid / Q000503:physiopathology* / Q000821:virology*; D008254:Macaca nemestrina; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D012367:RNA, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D012191:Retroviridae Proteins / Q000096:biosynthesis; D016097:Simian Acquired Immunodeficiency Syndrome / Q000134:cerebrospinal fluid / Q000150:complications / Q000276:immunology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000235:genetics* / Q000378:metabolism; D019562:Viral Load
chemical_list: D000914:Antibodies, Viral; D008562:Membrane Glycoproteins; D012367:RNA, Viral; D012191:Retroviridae Proteins; C082614:SIV envelope protein gp41